Pulse pressure as a predictor of stroke

Expert Review of Neurotherapeutics

Volumn 8, Issue 2, 2008, Pages 165-167

  Geeganage, Chamila ^a   Sare, Gillian ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; EPROSARTAN; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; NITRIC OXIDE DONOR; PRAZOSIN; THIAZIDE DIURETIC AGENT;

ACUTE DISEASE; ARTERIAL PRESSURE; ARTERY THROMBOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DETERIORATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME;

BLOOD PRESSURE; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE;

EID: 39549084556     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.2.165     Document Type: Editorial

References (28)

1. Williams B, Poulter NR, Brown MJ et al. British Hypertension Society guidelines for hypertension managment 2004 (BHS-IV): summary. Br. Med. J. 328, 634-640 (2004).
2. World Health Organization ISoHWG. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 21, 1983-1992 (2003).
3. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. 4th Edition. A Hodder Arnold Publication, London, UK (1998).
4. O'Rourke M, Frohlich ED. Pulse pressure: is this a clinically useful risk factor? Hypertension 34(3), 372-374 (1999).
5. Franklin SS, Gustin W, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure The Framingham Heart Study. Circulation 96, 308-315 (1997).
6. Franklin SS, Larson MG, Khan SA et al. Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation 103, 1245-1249 (2001).
7. Blacher J, Staessen JA, Girerd X et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med. 160, 1085-1089 (2000).
8. Gasowski J, Fagard RH, Staessen JA et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J. Hypertens. 20(1), 145-151 (2002).
9. Franklin SS, Larson MG, Khan SA et al. Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation 103, 1245-1249 (2001).
10. Liao D, Arnett DK, Tyroler HA et al. Arterial stiffness and the development of hypertension. Hypertension 34, 201-206 (1999).
11. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA 281, 634-643 (1999).
12. Staessen JA, Fagard R, Thijs L, Celis H. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350, 757-764 (1997).
13. Liu L, Wang J-G, Gong L, Liu G, Staessen JA for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J. Hypertens. 16, 1823-1829 (1998).
14. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M. Mortality and morbidity results from the European Working Party on High blood pressure in the Elderly trial. Lancet 1(8442), 1349-1354 (1985).
15. Staessen JA, Thijsa L, O'Brienb ET et al. Ambulatory pulse pressure aspredictor of outcome in older patients with systolic hypertension. Am. J. Hypertens 15, 835-843 (2002).
16. Vemmos KN, Tsivgoulis G, Spengos K et al. Pulse pressure in acute stroke is an independent predictor of long-term mortality. Cerebrovasc. Dis. 18(1), 30-36 (2004).
17. Voyaki SM, Efstratopoulos AD, Baltas A. Pulse pressure as a predictor factor for survival in patients with a acute ischaemic stroke. Am. J. Hypertens. 17(5), 234-235 (2004).
18. Tsivgoulis G, Spengos K, Zakopoulos N et al. Twenty four hour pulse pressure predicts long term recurrence in acute stroke patients. J. Neurol. Neurosurg. Psychiatr. 76, 1360-1365 (2005).
19. Sprigg N, Gray LJ, Bath PMW et al. Relationship between outcome and baseline blood pressure and other haemodynamic mreasures in acute ischaemic stroke: data from the TAIST trial. J. Hypertens. 24(7), 1413-1417 (2006).
20. Cushman WC, Materson BJ, Williams DW, Reda DJ, Agents ftVACSGoA. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial. Hypertension 38, 953-957 (2001).
21. Neaton JD, Grimm RH Jr, Prineas RJ et al. Treatment of mild hypertension study. Final results. JAMA 270(6), 713-724 (1993).
22. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283(15), 1967-1975 (2000).
23. ALLHAT Officers and Coordinators for the ALLHAtT Collaborative Research Group. Major outcomes in high risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blockers vs antihypertensive and lipid-lowering treatment to prevent heart attack. JAMA 288, 2981-2997 (2002).
24. Gray LJ, Sprigg N, Rashid PA, Willmot M, Bath PMW. Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subactue stroke. J. Stroke Cerebrovasc. Dis. 15(6), 245-249 (2006).
25. de la Sierra A, Muñoz A, Arcos E, López JS, Relats J. The effect of treatment with eprosartan on pulse pressure: factors predicting response. Can. J. Cardiol. 20(Suppl. C), C:17C-22C (2004).
26. Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients. Int. J. Clin. Pract. 59(4), 478-484 (2005).
27. de la Sierra A. Effects of eprosartan on pulse pressure. J. Clin. Basic Cardiol. 8, 11-14 (2005).
28. The ENOS Trial Investigators. Glyceryl trinitrave vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int. J. Stroke 1, 245-249 (2006).